XJ5-36140-61695
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 802 / CO
- Registered
- 2021-09-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-10
Registered in v-safe
-
2021-09-10
Dose 1 — Pfizer-BioNTech
- 2021-09-10
- 2021-09-11
- 2021-09-13
- 2021-09-14
-
2021-09-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-17
- 2021-09-24
-
2021-10-01
Dose 2 — Pfizer-BioNTech
-
2021-10-01
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-05
- 2021-10-17
-
2021-11-14
Survey response — day 42, dose 2MedDRA: Anosmia, Cough, Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Head cold, cough, loss of smellMedDRA releases: 2024-11 · check-in free text available
- 2022-01-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-10 | Pfizer-BioNTech | No |
| 2 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 10 — day 42, dose 2
Symptoms: Head cold, cough, loss of smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release